Krzysztof B.
- Country
- Poland
- Department
- N/A
Research Overview
- A Randomized, Double-Blind, Placebo-Controlled Study of AUR200 in Generalized Myasthenia Gravis
- Pharmacokinetic Non‑Inferiority and Safety of Subcutaneous IGSC 20% (Xembify) vs Intravenous IGIV‑C 10% (Gamunex‑C) in Adults with CIDP
- Evaluation of Safety and Efficacy of PRI-002 in Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 75 of 202 partner sites.
Specializations
Neurodegenerative Disorders
This investigator specializes in the treatment of Alzheimer's disease, with particular focus on patients experiencing mild cognitive impairment (MCI) and mild dementia. Their research extends to evaluating novel therapeutic approaches for cognitive decline and memory disorders.
- Early-stage Alzheimer's interventions
- Cognitive function assessment
- Dementia management strategies
Movement Disorders
The investigator conducts research in Parkinson's Disease treatment, specifically focusing on tremor management. Their work includes evaluation of innovative therapies for addressing motor symptoms and functional impairment in Parkinson's patients.
- Tremor control interventions
- Motor function improvement
- Daily function enhancement
Neurological Conditions
Their expertise encompasses both Multiple Sclerosis and Myasthenia Gravis, focusing on progressive forms of MS and generalized MG. The research spans therapeutic approaches for managing these chronic neurological conditions.
- Progressive MS management
- Myasthenia Gravis treatment
- Neuromuscular disorder interventions
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.